Bu sayfanın çevirisi deneyseldir ve geliştirilme aşamasındadır. imlerinizi bekliyoruz!

LifeMD Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 2/6

LifeMD has a total shareholder equity of $-2.1M and total debt of $18.1M, which brings its debt-to-equity ratio to -880.9%. Its total assets and total liabilities are $63.8M and $65.9M respectively.

Anahtar bilgiler

-880.9%

Borç/özkaynak oranı

US$18.14m

Borç

Faiz karşılama oranın/a
NakitUS$35.70m
Eşitlik-US$2.06m
Toplam yükümlülüklerUS$65.88m
Toplam varlıklarUS$63.82m

Son finansal sağlık güncellemeleri

Recent updates

LifeMD: Are The Commons Too Cheap?

Sep 23

LifeMD: Selling WorkSimpli Could Be A Catalyst

Sep 10

It's Down 27% But LifeMD, Inc. (NASDAQ:LFMD) Could Be Riskier Than It Looks

Aug 16
It's Down 27% But LifeMD, Inc. (NASDAQ:LFMD) Could Be Riskier Than It Looks

LifeMD: High Growth GLP-1 Telehealth Play At A Discount

Jul 31

LifeMD: Pairing GLP-1 Agonists With Virtual Healthcare

Jun 11

LifeMD: Moving Towards Profitability

May 22

Is LifeMD (NASDAQ:LFMD) Using Debt Sensibly?

Apr 25
Is LifeMD (NASDAQ:LFMD) Using Debt Sensibly?

Even With A 29% Surge, Cautious Investors Are Not Rewarding LifeMD, Inc.'s (NASDAQ:LFMD) Performance Completely

Mar 30
Even With A 29% Surge, Cautious Investors Are Not Rewarding LifeMD, Inc.'s (NASDAQ:LFMD) Performance Completely

LifeMD: Results And Guidance Point To Continued Strength In Weight Management Program

Mar 13

LifeMD's 2024: Striking A Balance Between Rapid Expansion And Sustainability

Jan 22

LifeMD: A GLP-1 Play With A Kicker

Jan 11

Is LifeMD, Inc. (NASDAQ:LFMD) Potentially Undervalued?

Jan 05
Is LifeMD, Inc. (NASDAQ:LFMD) Potentially Undervalued?

Take Care Before Jumping Onto LifeMD, Inc. (NASDAQ:LFMD) Even Though It's 34% Cheaper

Jan 05
Take Care Before Jumping Onto LifeMD, Inc. (NASDAQ:LFMD) Even Though It's 34% Cheaper

Does This Valuation Of LifeMD, Inc. (NASDAQ:LFMD) Imply Investors Are Overpaying?

Dec 03
Does This Valuation Of LifeMD, Inc. (NASDAQ:LFMD) Imply Investors Are Overpaying?

Investors Still Aren't Entirely Convinced By LifeMD, Inc.'s (NASDAQ:LFMD) Revenues Despite 38% Price Jump

Apr 17
Investors Still Aren't Entirely Convinced By LifeMD, Inc.'s (NASDAQ:LFMD) Revenues Despite 38% Price Jump

Analysts Are Betting On LifeMD, Inc. (NASDAQ:LFMD) With A Big Upgrade This Week

Nov 17
Analysts Are Betting On LifeMD, Inc. (NASDAQ:LFMD) With A Big Upgrade This Week

LifeMD launches at-home screening kits for breast, colon cancers

Sep 14

LifeMD Non-GAAP EPS of -$0.22 beats by $0.01, revenue of $30.5M misses by $1.45M

Aug 11

LifeMD CEO Justin Schreiber - Disrupting Healthcare With Telemedicine

Jan 10

Finansal Durum Analizi

Kısa Vadeli Yükümlülükler: LFMD has negative shareholder equity, which is a more serious situation than short term assets not covering short term liabilities.

Uzun Vadeli Yükümlülükler: LFMD has negative shareholder equity, which is a more serious situation than short term assets not covering long term liabilities.


Borç-Özkaynak Tarihçesi ve Analizi

Borç Seviyesi: LFMD has negative shareholder equity, which is a more serious situation than a high debt level.

Borcun Azaltılması: LFMD's has negative shareholder equity, so we do not need to check if its debt has reduced over time.


Bilanço


Nakit Pist Analizi

Geçmişte ortalama olarak zarar eden şirketler için, en az 1 yıllık nakit akışına sahip olup olmadıklarını değerlendiriyoruz.

İstikrarlı Nakit Pisti: Whilst unprofitable LFMD has sufficient cash runway for more than 3 years if it maintains its current positive free cash flow level.

Tahmini Nakit Akışı: LFMD is unprofitable but has sufficient cash runway for more than 3 years, even with free cash flow being positive and shrinking by 18.4% per year.


Sağlıklı şirketleri keşfedin